Related Experiment Video
Updated: May 26, 2026

Evaluating the Effect of Roadside Parking on a Dual-Direction Urban Street
Published on: January 20, 2023
Review of modeling approaches for emergency department patient flow and crowding research
Jennifer L Wiler1, Richard T Griffey, Tava Olsen
1Division of Emergency Medicine, Washington University in St. Louis School of Medicine, MO, USA. jennifer.wiler@ucdenver.edu
Abstract:
Emergency department (ED) crowding is an international phenomenon that continues to challenge operational efficiency. Many statistical modeling approaches have been offered to describe, and at times predict, ED patient load and crowding. A number of formula-based equations, regression models, time-series analyses, queuing theory-based models, and discrete-event (or process) simulation (DES) models have been proposed. In this review, we compare and contrast these modeling methodologies, describe the fundamental assumptions each makes, and outline the potential applications and limitations for each with regard to usability in ED operations and in ED operations and crowding research.
More Related Videos
Related Concept Videos
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

